2027届高三英语一轮复习 热点时事语法填空专项(40-42)
2027届高三英语一轮复习 热点时事语法填空专项(40-42)
本期导读:
Passage 40 我国首次实现火箭陆地回收
Another breakthrough in China's rocket development.
Passage 41 中国电动汽车走向全球
China's Electric Cars Are Going Global
Passage 42 全球首个mRNA癌症疫苗三期试验取得突破
语法填空:
Passage 40我国首次实现火箭陆地回收
Another breakthrough in China's rocket development.
On Wednesday, China's reusable Zhuque‑3 Y‑2 rocket lifted off from the Dongfeng Commercial Space Innovation Pilot Zone in northwest China. It sent the Honghu‑03 satellite into 1 (it) orbit.
But the more eye‑catching part is this: Less than 10 minutes after launch, the rocket's first stage successfully completed this planned land recovery procedure, 2 (achieve) full success of the flight‑test mission. The mission marked China's first flight verification of land recovery for the first stage of a reusable launch vehicle. It also achieved the country's first successful verification of a landing 3 deployable landing legs. LandSpace, the company behind the Zhuque‑3 rocket, is already looking ahead." This mission achieves a breakthrough in the first step toward making rockets ' 4 (recover), reusable, and operational.' 5 (significant), recovery matters a great deal for subsequent reuse and operation. At present, the Zhuque‑3 rocket is designed to meet the technical requirements of reusing its first stage 20 times.
In the operational phase, the goal is to bring space flight close to aviation — to make rocket launches and landings more like airplane operations, with an optimal
1
学科网(北京)股份有限公司
balance of frequency, 6 (reliable) and safety. This successful test mission is viewed as 7 important step in China's reusable rocket development, and more flight tests for the country's reusable rockets 8 (expect) in the coming months.
Such reusable rockets will greatly cut the cost of space launches, 9 will lay a solid groundwork for China's future deep‑space exploration. Many space fans are 10 (convince) China will make more remarkable achievements in aerospace.
Passage 41中国电动汽车走向全球
China's Electric Cars Are Going Global
For many years, China's electric vehicle industry grew mainly because of strong support from the government and high demand at home. Now, Chinese car‑makers are expanding into overseas markets and 1 (challenge) some of the world's oldest automobile companies.
Companies such as BYD, Geely, Chery and SAIC have increased their presence in Europe, Southeast Asia and other regions. Their electric vehicles are highly 2 (compete), thanks to reasonable prices, advanced battery technology and attractive designs. BYD reported strong global sales growth in June 2026, 3 exports playing an important role even as competition in China became fierce.
One key reason for their success lies in China's advantage in battery technology and manufacturing efficiency. China has built 4 complete supply chain for electric vehicles, covering battery production, raw materials, electronics and vehicle assembly. This helps 5 (great) bring down production costs and speed up new‑model launch.
However, Chinese automakers face various overseas challenges. Some countries have carried out restrictive measures 6 (defend) their domestic car industries. Despite these 7 (difficult), Chinese electric vehicles represent a significant turning point in the global auto sector. 8 impresses industry specialists most is the pace of China's industrial transformation, 9 few competitors can match. Many experts hold the 10 (believe) that the industry will keep moving forward.
1
学科网(北京)股份有限公司
Passage 42全球首个mRNA癌症疫苗三期试验取得突破
A potentially pivotal moment has arrived in the fight 1 high‑risk melanoma. A new mRNA vaccine, 2 (combine) with the immunotherapy drug Keytruda, has produced clinically meaningful improvements, preventing the cancer from 3 (return) in a large‑scale trial.
Melanoma is a severe form of skin cancer which claims over 8,000 lives 4 (annual). Dr. Michael Postow took part in the trial. “Other kinds of cancer vaccines 5 (approve) generally, but this is the first personalized cancer vaccine to show benefits in a Phase‑Three study so far,” he remarked.
Here is how it operates: Doctors first carry out the 6 (remove) of the melanoma tumor. The patient receives Keytruda treatment. Meanwhile, the tumor and blood samples are examined to spot unique mutations, based on 7 the vaccine is created. The whole procedure lasts about six weeks.
Moderna and Merck, 8 (develop) of this experimental cure, witnessed their share prices rise sharply after the news came out. More details about trial results 9 (expect) to be released 10 (late) this year.
1
学科网(北京)股份有限公司